CTNNA2 Antikörper
Kurzübersicht für CTNNA2 Antikörper (ABIN7384073)
Target
Alle CTNNA2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Affinity purification
-
Immunogen
- Recombinant fusion protein of human CTNNA2 (NP_004380.2).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB 1:200-1:2000 IHC 1:50-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- CTNNA2 (Catenin (Cadherin-Associated Protein), alpha 2 (CTNNA2))
-
Andere Bezeichnung
- CTNNA2
-
Hintergrund
- CTNNA2,CAP-R,CAPR,CT114,CTNR,CTNNA2 (Catenin Alpha 2) is a Protein Coding gene. Diseases associated with CTNNA2 include Cortical Dysplasia, Complex, With Other Brain Malformations 9 and Arrhythmogenic Right Ventricular Cardiomyopathy. Among its related pathways are Blood-Brain Barrier and Immune Cell Transmigration: VCAM-1/CD106 Signaling and Gastric cancer. Gene Ontology (GO) annotations related to this gene include structural molecule activity and structural constituent of cytoskeleton. An important paralog of this gene is CTNNA1.
-
Molekulargewicht
-
Observed_MW: 120 kDa
Calculated_MW: 59 kDa/65 kDa/95 kDa/100 kDa/104 kDa/105 kDa
-
Gen-ID
- 1496
-
UniProt
- P26232
-
Pathways
- Regulation of Muscle Cell Differentiation
Target
-